Abiopharma

🔍 Le-Quoc Alexis (Director)

Company: Datadog, Inc. (DDOG)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 10,688 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: C | equity_swap_involved: 0 | shares_owned_after: 541,999.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 32,418 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: C | equity_swap_involved: 0 | shares_owned_after: 574,417.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,044 shares of Class A Common Stock at $140.3373 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 572,373.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 1,956 shares of Class A Common Stock at $141.2317 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 570,417.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 2,800 shares of Class A Common Stock at $142.384 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 567,617.00 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 2,700 shares of Class A Common Stock at $143.4552 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 564,917.00 | transaction_form_type: 4 | Footnotes: F2, F6
• Sold 5,634 shares of Class A Common Stock at $144.3645 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 559,283.00 | transaction_form_type: 4 | Footnotes: F2, F7
• Sold 10,898 shares of Class A Common Stock at $145.2715 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 548,385.00 | transaction_form_type: 4 | Footnotes: F2, F8
• Sold 14,824 shares of Class A Common Stock at $146.4689 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 533,561.00 | transaction_form_type: 4 | Footnotes: F2, F9
• Sold 2,250 shares of Class A Common Stock at $146.9591 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 531,311.00 | transaction_form_type: 4 | Footnotes: F2, F10
• Acquired 10,806 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: C | equity_swap_involved: 0 | shares_owned_after: 542,117.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,806 shares of Class A Common Stock at $150.0 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 531,311.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-04 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 169.00 | Footnotes: F11
• Sold 18,750 shares of Stock Option (Right to Buy) at $10.74 per share (Derivative)
  Date: 2026-05-04 | Code: M | Expires: 2029-07-19 | equity_swap_involved: 0 | shares_owned_after: 206,250.00 | transaction_form_type: 4 | Footnotes: F12
• Acquired 18,750 shares of Class B Common Stock (Derivative)
  Date: 2026-05-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,570,710.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 10,688 shares of Class B Common Stock (Derivative)
  Date: 2026-05-04 | Code: C | equity_swap_involved: 0 | shares_owned_after: 2,560,022.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 32,418 shares of Class B Common Stock (Derivative)
  Date: 2026-05-04 | Code: C | equity_swap_involved: 0 | shares_owned_after: 2,527,604.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 10,806 shares of Class B Common Stock (Derivative)
  Date: 2026-05-05 | Code: C | equity_swap_involved: 0 | shares_owned_after: 2,516,798.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Holds 6,203,835 shares of Class B Common Stock (Derivative)
  Date: 2026-05-04 | Code: H | shares_owned_after: 6,203,835.00 | Footnotes: F1, F1, F1, F11

Footnotes:

• F1: Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon the earliest of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's amended and restated certificate of incorporation, (ii) the death of the Reporting Person in the case of shares held directly or in a trustee capacity, and (iii) the tenth anniversary of the Issuer's initial public offering of its Class A Common Stock.
• F2: Shares sold pursuant to a 10b5-1 plan dated June 13, 2025.
• F3: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $139.75 to $140.73. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F4: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $140.75 to $141.70. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F5: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $141.83 to $142.80. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F6: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $142.83 to $143.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F7: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $143.83 to $144.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F8: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $144.83 to $145.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F9: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $145.83 to $146.82. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F10: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $146.83 to $147.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
• F11: Shares are held by the Alexis Le-Quoc Revocable Trust.
• F12: Option is fully vested and exercisable.